Infectious disease · Phase III

Top sponsors

• United Therapeutics Europe 22 programs
• GSK Glaxo Smith 20 programs
• BRIGHT MINDS BIOSCIENCES 18 programs
• Chinese Academy of 13 programs
• Takeda 12 programs
• Sinovac Research and 11 programs
• Gilead Sciences Ireland 10 programs
• PARItec 10 programs
• Gilead Sciences 9 programs
• Pfizer 8 programs
• Vir Biotechnology 7 programs
• George Institute for 6 programs

1. Eltrombopag

   GlaxoSmithKline

   Non-alcoholic Steatohepatitis

   phase 3 · small molecule · terminated

   1 trial →

2. Entecavir

   Hoffmann-La Roche

   Pediatric Immuno-Tolerant Chronic Hepatitis B

   phase 3 · small molecule · completed

   1 trial →

3. Entecavir

   Bristol-Myers Squibb

   Hepatitis B, Chronic

   phase 3 · small molecule · completed

   1 trial →

4. Ertapenem

   Iterum Therapeutics plc

   Intra Abdominal Infections

   phase 3 · small molecule · completed

   1 trial →

5. Erythromycin

   BRIGHT MINDS BIOSCIENCES INC.

   HIV Infections

   phase 3 · small molecule · completed

   1 trial →

6. Evolocumab

   COLLEGIUM PHARMACEUTICAL, INC

   Sars-CoV-2 Infection

   phase 3 · small molecule · completed

   1 trial →

7. FMGX-CS-302

   Lacuna Pharma Pty Ltd

   Invasive mold infections caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans, Mucorales fungi, or other multidrug resistant molds

   phase 3 · small molecule · active

   1 trial →

8. FUR-05-24

   Lacuna Pharma Pty Ltd

   Bacterial vaginosis

   phase 3 · small molecule · active

   1 trial →

9. Flomoxef

   Takeda

   Urinary Tract Infection

   phase 3 · small molecule · terminated

   1 trial →

10. Formosa 1-Breath Free (NRICM101)

    Hospital Authority, Hong Kong

    Influenza Viral Infections

    phase 3 · small molecule · active

    1 trial →

11. Fostamatinib

    RIGEL PHARMACEUTICALS INC

    Covid19

    phase 3 · small molecule · completed

    1 trial →

12. GC1107

    Green Valley (Shanghai) Pharmaceuticals Co.,

    Bacterial Infections

    phase 3 · mab · completed

    1 trial →

13. GS-5245 tablets 175 mg, GS-5245 tablets 350 mg

    Gilead Sciences Pty Limited

    COVID-19

    phase 3 · small molecule · active

    1 trial →

14. GS-US-174-0144

    Gilead Sciences Pty Limited

    Hepatitis B Infection

    phase 3 · small molecule · active

    1 trial →

15. GS-US-528-6727

    Gilead Sciences Pty Limited

    Human Immunodeficiency Virus (HIV-1) infection

    phase 3 · small molecule · active

    1 trial →

16. GS-US-563-5925

    Gilead Sciences Pty Limited

    HIV-1 Infection

    phase 3 · small molecule · active

    1 trial →

17. GS-US-563-5926

    Gilead Sciences Pty Limited

    HIV-1 Infection

    phase 3 · small molecule · active

    1 trial →

18. GS-US-621-6290

    Gilead Sciences Pty Limited

    HIV-1 infection

    phase 3 · small molecule · active

    1 trial →

19. GS-US-621-6463

    Gilead Sciences Pty Limited

    HIV-1 Infection

    phase 3 · small molecule · active

    1 trial →

20. GS-US-695-6509

    Gilead Sciences Pty Limited

    HIV-1 Infection

    phase 3 · small molecule · active

    1 trial →

21. GS-US-695-7156

    Gilead Sciences Pty Limited

    HIV-1 Infection

    phase 3 · small molecule · active

    1 trial →

22. Gepotidacin

    GlaxoSmithKline

    Urinary Tract Infections

    phase 3 · small molecule · completed

    1 trial →

23. Glecaprevir/Pibrentasvir

    AbbVie

    Hepatitis C Virus (HCV)

    phase 3 · small molecule · completed

    2 trials →

24. Gynaecological follow-up

    GlaxoSmithKline

    Infections, Papillomavirus

    phase 3 · other · completed

    1 trial →

25. H. pylori vaccine

    Jiangsu Province Centers for Disease Control and Prevention

    H. Pylori Infection

    phase 3 · mab · completed

    1 trial →

26. H. pylori vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    H. Pylori Infection

    phase 3 · mab · completed

    1 trial →

27. HEC74647PA+HEC110114

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic HCV Infection

    phase 3 · small molecule · completed

    1 trial →

28. Hepatitis B adjuvanted vaccine

    GlaxoSmithKline

    Hepatitis B

    phase 3 · mab · completed

    1 trial →

29. Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Norovirus Infections

    phase 3 · mab · completed

    1 trial →

30. Human rotavirus liquid vaccine

    GlaxoSmithKline

    Infections, Rotavirus

    phase 3 · mab · completed

    1 trial →

31. INO-4800

    INOVIO PHARMACEUTICALS, INC.

    Coronavirus Infection

    phase 3 · small molecule · completed

    4 trials →

32. INS-416

    Insmed Limited

    "Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)"

    phase 3 · small molecule · active

    1 trial →

33. ITDCVC98

    United Therapeutics Europe Ltd

    Malaria

    phase 3 · small molecule · completed

    1 trial →

34. Inactivated COVID-19 Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 · mab · completed

    4 trials →

35. Influenza vaccine

    Lxo Ireland Designated Activity Company

    Infection in Solid Organ Transplant Recipients

    phase 3 · mab · completed

    1 trial →

36. Intervention

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HIV

    phase 3 · other · active

    1 trial →

37. Intravenous methylene blue administration

    Hospital Authority, Hong Kong

    Severe Sepsis

    phase 3 · small molecule · active

    1 trial →

38. KLWS-V502-04

    BRIGHT MINDS BIOSCIENCES INC.

    Human Papillomavirus Infection

    phase 3 · mab · active

    1 trial →

39. Keverprazan Hydrochloride tablets + high dose amoxicillin

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education

    phase 3 · small molecule · active

    1 trial →

40. LDV/SOF

    Gilead Sciences Ireland UC

    Hepatitis C Virus

    phase 3 · small molecule · completed

    1 trial →

41. LY3819253

    Vir Biotechnology

    Covid19

    phase 3 · mab · completed

    1 trial →

42. Losmapimod oral tablet

    Fulcrum Therapeutics

    COVID-19

    phase 3 · small molecule · terminated

    1 trial →

43. MEQ00073

    Sanofi Pasteur

    Meningococcal infection

    phase 3 · small molecule · active

    1 trial →

44. MEQ00074

    Sanofi Pasteur

    Meningococcal Infection

    phase 3 · mab · completed

    1 trial →

45. MEQ00089

    Sanofi Pasteur

    Healthy volunteers (Meningococcal infection)

    phase 3 · small molecule · active

    1 trial →

46. METFORMIN for PASC: post-acute sequelae of SARS-CoV-2 infection

    Disc Medicine

    PASC: post-acute sequelae of SARS-CoV-2 infection

    phase 3 · small molecule · active

    1 trial →

47. METFORMIN, COLCHICINE

    Disc Medicine

    PASC: post-acute sequelae of SARS-CoV-2 infection

    phase 3 · small molecule · active

    1 trial →

48. METHYLPREDNISOLONE , ACETYLCYSTEINE

    The George Institute

    Acute Alcoholic hepatitis

    phase 3 · small molecule · active

    1 trial →

Frequently asked questions